What Is The Reason Why GLP1 Cost In Germany Are So Helpful When COVID-19 Is In Session

· 6 min read
What Is The Reason Why GLP1 Cost In Germany Are So Helpful When COVID-19 Is In Session

The pharmaceutical landscape in Germany has actually seen a considerable shift just recently with the intro and rising popularity of GLP-1 (Glucagon-like peptide-1) receptor agonists. Initially established to deal with Type 2 diabetes, medications like Ozempic and Wegovy have gained international popularity for their weight-loss efficacy. For locals and expatriates in Germany, comprehending the expense, reimbursement structure, and schedule of these drugs is important.

Germany runs under a special two-tier health care system including statutory health insurance coverage (Gesetzliche Krankenversicherung or GKV) and private medical insurance (Private Krankenversicherung or PKV). This structure, integrated with rigorous federal policies on pharmaceutical rates, makes the expense of GLP-1 medications in Germany quite different from that in the United States or other European nations.

What are GLP-1 Medications?

GLP-1 receptor agonists are a class of medications that simulate a natural hormone in the body. They operate by:

  1. Increasing insulin secretion in reaction to high blood sugar level.
  2. Slowing stomach emptying (making the stomach feel complete longer).
  3. Acting on the brain to suppress cravings and lower yearnings.

Typical GLP-1 medications offered in Germany consist of:

  • Semaglutide: Marketed as Ozempic (for diabetes) and Wegovy (for weight-loss).
  • Tirzepatide: Marketed as Mounjaro (a double GLP-1/ GIP receptor agonist).
  • Liraglutide: Marketed as Saxenda (daily injection).
  • Oral Semaglutide: Marketed as Rybelsus (tablet form).

The Cost Breakdown: Self-Pay vs. Insurance Coverage

In Germany, the price of a medication is extremely dependent on whether it is being utilized for its primary medical indication (like Type 2 diabetes) or as a "way of life" treatment (like weight-loss).

Statutory Health Insurance (GKV)

If a client has Type 2 diabetes, the GKV typically covers the cost of medications like Ozempic or Rybelsus. In this case, the client pays only a little co-payment (Zuzahlung), usually ranging from EUR5 to EUR10 per prescription.

However, for weight management, the situation changes. Under Section 20 of the Social Code Book V (SGB V), medications mainly meant for "enhancing the lifestyle" or weight reduction are presently excluded from GKV coverage. This implies patients using Wegovy or Saxenda for weight-loss should typically pay the full retail cost out-of-pocket.

Private Health Insurance (PKV)

Private insurance companies have more flexibility. Depending upon the particular tariff and medical requirement, some personal insurance companies might reimburse the cost of weight-loss medications if the patient satisfies particular requirements, such as a high BMI (usually >> 30 )and accompanying comorbidities (high blood pressure, sleep apnea).


Relative Cost Table for GLP-1 Medications in Germany

The following table provides a quote of out-of-pocket costs for the most popular GLP-1 medications in Germany since late 2023/early 2024. Costs might differ slightly in between drug stores but are controlled by the Arzneimittelpreisverordnung (Medicines Price Ordinance).

MedicationMain UsageTypeApprox. Month-to-month Cost (Self-Pay)
OzempicType 2 DiabetesWeekly InjectionEUR80 - EUR90
Wegovy (Low Dose)Weight LossWeekly InjectionEUR170 - EUR190
Wegovy (High Dose)Weight LossWeekly InjectionEUR300 - EUR320
MounjaroDiabetes/ ObesityWeekly InjectionEUR260 - EUR330
SaxendaWeight reductionDaily InjectionEUR250 - EUR300
RybelsusType 2 DiabetesDaily TabletEUR100 - EUR140

Note: Costs represent the "Apothekenverkaufspreis" (Pharmacy Retail Price) for clients with a personal prescription.


Detailed Look at Wegovy Pricing in Germany

Wegovy was launched in Germany in July 2023. Unlike the United States, where rates can exceed ₤ 1,000 each month, the German market gain from government-negotiated pricing, though it stays costly for the typical consumer.

The expense of Wegovy in Germany scales somewhat with the dose.  GLP-1-Angebote in Deutschland -week supply contains one pen that enables four dosages.

Common Wegovy Price Tiers:

  • 0.25 mg, 0.5 mg, and 1.0 mg: Generally priced around EUR171.92 per 4-week supply.
  • 1.7 mg: Priced around EUR237.91 per 4-week supply.
  • 2.4 mg (Maintenance Dose): Priced around EUR301.91 per 4-week supply.

Why is it cheaper in Germany than the US?

The disparity in between German and American drug prices is a frequent topic of debate. The lower costs in Germany are credited to:

  1. Price Caps: The German federal government sets an optimal price for brand-new drugs after an initial period on the marketplace.
  2. Centralized Negotiations: Statutory health insurance coverage funds work out jointly with pharmaceutical manufacturers.
  3. Drug store Regulations: Pharmacy markups are strictly regulated by law, avoiding significant cost gouging at the retail level.

How to Obtain a GLP-1 Prescription in Germany

No matter whether a patient is paying out-of-pocket or through insurance coverage, GLP-1 medications are prescription-only (verschreibungspflichtig).

  1. Assessment: The patient needs to check out a General Practitioner (GP/Hausarzt) or an Endocrinologist.
  2. Medical Screening: The medical professional will carry out blood tests (HbA1c, kidney function) and calculate BMI to make sure the medication is safe and indicated.
  3. Prescription Types:
  • Red Prescription (Muster 16): For GKV clients (The insurance company pays, the client pays a EUR5-10 co-pay).
  • Blue Prescription: For PKV clients or "Selbstzahler" (self-pay patients).
  • Green Prescription: A recommendation from the doctor for non-prescription or self-pay products (less common for GLP-1s).

Supply Shortages and the "Off-Label" Issue

Germany, like the remainder of the world, has dealt with significant shortages of Ozempic. Because Ozempic is more affordable than Wegovy (approx. EUR80 vs EUR170+),  GLP-1-Onlineshop in Deutschland  looked for "off-label" prescriptions for weight reduction.

To combat this, the German Federal Institute for Drugs and Medical Devices (BfArM) has provided standards advising medical professionals to just recommend Ozempic for its authorized indicator: Type 2 Diabetes. This is to guarantee that diabetic clients do not lose access to their life-saving medication.


Often Asked Questions (FAQ)

1. Does the GKV pay for Wegovy for weight-loss?

Currently, no. Wegovy is classified as a "way of life drug" in Germany. Despite current discussions in the Bundestag regarding the increasing costs of weight problems, the statutory health insurance coverage funds are lawfully barred from covering obesity-only medications.

2. Can I use a private prescription at any German drug store?

Yes. Any certified pharmacy in Germany (consisting of online pharmacies like DocMorris or Shop Apotheke) can satisfy a personal prescription for GLP-1 medications, offered they have the stock.

3. Is Tirzepatide (Mounjaro) available in Germany?

Yes, Mounjaro was recently launched in the German market.  Kosten für ein GLP-1-Rezept in Deutschland  is available in the "KwikPen" format. Costs are presently higher than Ozempic but competitive with Wegovy's maintenance dosages.

4. Are there any covert expenses?

Beyond the medication, clients must account for the cost of the physician's assessment. For GKV clients, this is covered. For private/self-pay clients, a consultation can cost between EUR30 and EUR100 depending on the intricacy of the test.

5. Can I buy GLP-1 meds online without a prescription?

No. It is illegal and extremely unsafe to acquire these medications without a prescription. Germany has rigorous laws versus "Fernabsatz" (mail order) of prescription drugs from non-certified sources. Counterfeit Ozempic pens have been discovered in the European supply chain.


Summary Checklist for Patients in Germany

If you are thinking about GLP-1 therapy in Germany, keep the following points in mind:

  • Check Qualification: Ensure your BMI is over 30, or over 27 with weight-related health concerns.
  • Budgeting: If you are not diabetic, expect to pay in between EUR170 and EUR310 monthly for semaglutide.
  • Insurance coverage: If you are independently insured, call your company before your very first dosage to inquire about "Antrag auf Kostenübernahme" (demand for cost protection).
  • Pharmacy Availability: Call ahead to your local pharmacy to ensure they have the dosage in stock, as supply chains remain unpredictable.
  • Security: Always get your medication through a physical or validated German online pharmacy to prevent fake products.

The cost of GLP-1 medications in Germany reflects the country's more comprehensive method to healthcare: managed, fairly cost effective compared to the international market, but strictly partitioned in between medical requirement and optional treatment. While diabetic clients take advantage of very low co-payments, those looking for these drugs for weight loss should be gotten ready for a substantial regular monthly financial investment. As clinical evidence continues to show the long-lasting health advantages of weight decrease, numerous in the German medical community hope for a shift in insurance coverage legislation that might one day make these treatments more available to all.